Rob O’Connor
Associate
Corporate
Rob
O’Connor
Rob
O’Connor
Associate
Corporate
Rob advises public and private clients on a wide range of strategic transactions. He brings expertise in acquihires, divestitures, mergers and acquisitions, and a broad variety of corporate matters. Rob has advised clients on dozens of M&A transactions, totaling over $16 billion. His recent work includes representing Alpine Immune Sciences in its $4.9 billion acquisition by Vertex Pharmaceuticals—the highest value ever paid for a biotech company at its stage of the clinical-regulatory process.
Known for his expertise in the life sciences and technology industries, Rob's meticulous attention to detail and strategic approach to complex transactions consistently delivers exceptional results to his clients. Clients value his practical insights, reliability and unwavering commitment to their success.
While attending law school, he served as an article editor for the George Washington International Law Review.
- Alpine Immune Sciences in its $4.9B acquisition by Vertex Pharmaceuticals
- Morphic in its $3.2B acquisition by Eli Lilly
- DICE Therapeutics in its $2.4B acquisition by Eli Lilly
- Aliada Therapeutics in its $1.4B acquisition by AbbVie
- UserTesting in its $1.3B acquisition by Thoma Bravo and Sunstone Partners
- Escient Pharmaceuticals in its $750M acquisition by Incyte
- Wonder Group in its $103M acquisition of Blue Apron
- Aceragen in its acquisition by Idera Pharmaceuticals
- Encoding.com in its acquisition by Telestream
- GitLab in its acquisition of Oxeye
- Robinhood in its acquisition of Pluto
- SomaLogic in its merger with Standard BioTools
- Veracyte in its acquisition of C2i Genomics
- Alpine Immune Sciences in its $4.9B acquisition by Vertex Pharmaceuticals
- Morphic in its $3.2B acquisition by Eli Lilly
- DICE Therapeutics in its $2.4B acquisition by Eli Lilly
- Aliada Therapeutics in its $1.4B acquisition by AbbVie
- UserTesting in its $1.3B acquisition by Thoma Bravo and Sunstone Partners
- Escient Pharmaceuticals in its $750M acquisition by Incyte
- Wonder Group in its $103M acquisition of Blue Apron
- Aceragen in its acquisition by Idera Pharmaceuticals
- Encoding.com in its acquisition by Telestream
- GitLab in its acquisition of Oxeye
- Robinhood in its acquisition of Pluto
- SomaLogic in its merger with Standard BioTools
- Veracyte in its acquisition of C2i Genomics